Emerging resistance to newer antimicrobial agents among Shigella isolated from Finnish foreign travellers

Epidemiology and Infection

Volumn 136, Issue 4, 2008, Pages 476-482

  Haukka, K ^a   Siitonen, A ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MECILLINAM; NALIDIXIC ACID; NEOMYCIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHINA; FINLAND; GEOGRAPHICAL VARIATION (SPECIES); HUMAN; INDIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEROTYPING; SHIGELLA; SHIGELLA BOYDII; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; TRAVEL;

ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES, EMERGING; DRUG RESISTANCE, MICROBIAL; DYSENTERY, BACILLARY; FINLAND; HUMANS; MICROBIAL SENSITIVITY TESTS; SHIGELLA; TRAVEL;

EID: 40449096264     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807008862     Document Type: Article

References (30)

1. Ekdahl K, Andersson Y. The epidemiology of travel-associated shigellosis - regional risks, seasonality and serogroups. Journal of Infection 2005; 51: 222-229.
2. Cheasty T, Day M, Threlfall E.J. Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: Implications for therapy. Clinical Microbiology and Infection 2004; 10: 1033-1035.
3. Sivapalasingam S, et al. High prevalence of anti-microbial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2662. Antimicrobial Agents and Chemotherapy 2006; 50: 49-54.
4. Hirose K, et al. Antimicrobial susceptibility of Shigella sonnei isolates in Japan and molecular analysis of S. sonnei isolates with reduced susceptibility to fluoroquinolones. Antimicrobial Agents and Chemotherapy 2005; 49: 1203-1205.
5. Janda JM, Abbott SL. The Enterobacterial, 2nd edn. Washington, DC: ASM Press, 2006, pp. 411.
6. Sur D, et al. Shigellosis: Challenges and management issues. Indian Journal of Medical Research 2004; 120: 454-462.
7. Heymann DL. Control of Communicable Diseases Manual, 18th edn. Washington, DC: APHA, 2004, pp. 700.
8. Niyogi SK. Shigellosis. Journal of Microbiology 2005; 43 133-143.
9. Swedish Reference Group for Antibiotics. Antimicrobial Susceptibility Testing of Bacteria - A Reference and a Methodology Manual. Stockholm, Sweden: The Swedish Medical Society and Statens Bakteriologiska Laboratorium, 1990.
10. CLSI. Performance standards for antimicrobial susceptibility testing; M100-S16. Clinical and Laboratory Standards Institute, 2006.
11. Heikkilä E, et al. Increase in trimethoprim resistance among Shigella species, 1975-1988: Analysis of resistance mechanisms. Journal of Infectious Diseases 1990; 161: 1242-1248.
12. WHO. Shigellosis: Disease burden, epidemiology and case management. Weekly Epidemiological Record 2005; 80: 93-160.
13. Phavichitr N, Catto-Smith AG. Acute gastroenteritis in children: what role for antibacterials? Pediatric Drugs 2003; 5: 279-290.
14. Leibovitz E. The use of fluoroquinolones in children. Current Opinion in Pediatrics 2006; 18: 64-70.
15. Kim S, et al. Occurrence of extended-spectrum β-lactamases in membranes of the genus Shigella in the Republic of Korea. Journal of Clinical Microbiology 2004; 42: 5264-5269.
16. Andres P, et al. Extended-spectnun β-lactamases in Shigella flexneri from Argentina: First report of TOHO-1 outside Japan. International Journal of Antimicrobial Agents 2005; 25 501-507.
17. Rahman M, et al. Extended-spectrum β-lactamase-mediated third generation cephalosporin resistance in Shigella isolates in Bangladesh. Journal of Antimicrobial Chemotherapy 2004; 54: 846-847.
18. Wang XY, et al. Occurrence of shigellosis in the young and elderly in rural China: Results of a 12-month population-based surveillance study. American Journal of Tropical Medicine and Hygiene 2005; 73: 416-422.
19. von Seidlein L, et al. A multicentre study of Shigella diarrhoea in six Asian countries: Disease burden, clinical manifestations, and microbiology. PLOS Medicine 3: E353.
20. Wang X, et al. Trend and disease burden of bacillary dysentery in China (1991-2000). Bulletin of the World Health Organization 2006; 84: 561-568.
21. Pazhani GP, et al. Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiology and Infection 2005; 133: 1089-1095.
22. Talukder KA, et al. Antibiotic resistance and genetic diversity of Shigella sonnei isolated from patients with diarrhoea between 1999 and 2003 in Bangladesh. Journal of Medical Microbiology 2006; 55: 1257-1263.
23. Ahmed AM, et al. Genetic characterization of multidrug resistance in Shigella spp. from Japan. Journal of Medical Microbiology 2006; 55: 1685-1691.
24. Streit JM, et al. Prevalence and antimicrobial susceptibility patterns among gastroenteritis-causing pathogens recovered in Europe and Latin America and Salmonella isolates recovered from bloodstream infections in North America and Latin America: Report from the SENTRY Antimicrobial Surveillance Program, 2003. International Journal of Antimicrobial Agent 2006; 27: 367-375.
25. Brooks JT, et al. Surveillance for bacterial diarrhea and antimicrobial resistance in rural Western Kenya, 1997-2003. Clinical Infectious Diseases 2006; 43: 393-4011.
26. Naik DG. Prevalence and antimicrobial susceptibility patterns of Shigella, species in Asmara, Eritrea, Northeast Africa. Journal of Microbiology, Immunology and Infection 2006; 39: 392-395.
27. Putnam SD, et al. Antimicrobial susceptibility trends among Escherichia coli and Shigella spp. isolated from rural Egyptian paediatric populations with diarrhoea between 1995 and 2000. Clinical Microbiology and Infection 2004; 10:804-810.
28. Ahmed SF, et al. Epidemiology and genetic characterization of Shigella flexneri strains isolated from three paediatric populations in Ejypt, 2000-2004. Epidemiology and Infection 2006; 134: 1237-1248.
29. Ashkenazi S, et al. Growing antimicrobial resistance of Shigella isolates. Journal of Antimicrobial Chemotherapy 2003; 51: 427-429.
30. Eja ME, et al. Incidence of enteric bacterial pathogens in water found at the bottom of commercial freezers in Calabar, southeastern Nigeria. Southeast Asian Journal of Tropical Medicine and Public Health 2006; 37: 394-399.